SCHEMBL29937140

SCHEMBL29937140

Cc1cc2[nH]nc(I)c2c(Br)c1C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29344157 1.00
SCHEMBL24802950 0.76 AMY1A (0.32)
SCHEMBL18299332 0.76 IKBKB (0.37)
SCHEMBL23562909 0.71 PDPK1 (0.33)
SCHEMBL31393082 0.71 DYRK1A (0.32)
SCHEMBL26404730 0.71 AXL (0.31)
SCHEMBL29937175 0.71 AXL (0.31)
SCHEMBL25547735 0.70 DRD1 (0.33)
SCHEMBL31393075 0.69 DYRK1A (0.31)
SCHEMBL31642307 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4713330-A1 TRICYCLIC COMPOUNDS AND USES THEREOF HUTCHMED Limited (CN) 2026-03-25 EP disclosed
WO-2024235286-A1 TRICYCLIC COMPOUNDS AND USES THEREOF HUTCHMED LIMITED (CN) 2024-11-21 WO disclosed
EP-4322954-A1 SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT Merck Sharp & Dohme LLC (US) 2024-02-21 EP disclosed
WO-2022221739-A1 SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT MERCK SHARP & DOHME CORP. (US) 2022-10-20 WO disclosed